<VariationArchive VariationID="206429" VariationName="NM_007254.4(PNKP):c.1317_1321dup (p.Ala441fs)" VariationType="Duplication" Accession="VCV000206429" Version="15" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-05-01" DateCreated="2015-06-28" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="203579" VariationID="206429">
      <GeneList>
        <Gene Symbol="PNKP" FullName="polynucleotide kinase 3'-phosphatase" GeneID="11284" HGNC_ID="HGNC:9154" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="49861204" stop="49867576" display_start="49861204" display_stop="49867576" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="50364459" stop="50370821" display_start="50364459" display_stop="50370821" Strand="-" />
          </Location>
          <OMIM>605610</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_007254.4(PNKP):c.1317_1321dup (p.Ala441fs)</Name>
      <CanonicalSPDI>NC_000019.10:49861672:CGGCTCGG:CGGCTCGGCTCGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="49861672" stop="49861673" display_start="49861672" display_stop="49861673" variantLength="5" positionVCF="49861672" referenceAlleleVCF="G" alternateAlleleVCF="GCGGCT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="50364929" stop="50364930" display_start="50364929" display_stop="50364930" variantLength="5" positionVCF="50364929" referenceAlleleVCF="G" alternateAlleleVCF="GCGGCT" />
      </Location>
      <ProteinChange>A441fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.49861676_49861680dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.49861676_49861680dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.50364933_50364937dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.50364933_50364937dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027717.1" sequenceAccession="NG_027717" sequenceVersion="1" change="g.10889_10893dup">
            <Expression>NG_027717.1:g.10889_10893dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_050666.1" sequenceAccession="NG_050666" sequenceVersion="1" change="g.17833_17837dup">
            <Expression>NG_050666.1:g.17833_17837dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007254.4" sequenceAccession="NM_007254" sequenceVersion="4" change="c.1317_1321dup" MANESelect="true">
            <Expression>NM_007254.4:c.1317_1321dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_009185.2" sequenceAccession="NP_009185" sequenceVersion="2" change="p.Ala441fs">
            <Expression>NP_009185.2:p.Ala441fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007254.3" sequenceAccession="NM_007254" sequenceVersion="3" change="c.1317_1321dupAGCCG">
            <Expression>NM_007254.3:c.1317_1321dupAGCCG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA251238" DB="ClinGen" />
        <XRef Type="rs" ID="796052862" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_007254.4(PNKP):c.1317_1321dup (p.Ala441fs) AND not provided" Accession="RCV000188475" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2016-09-30" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_007254.4(PNKP):c.1317_1321dup (p.Ala441fs) AND Developmental and epileptic encephalopathy, 12" Accession="RCV001387495" Version="4">
        <ClassifiedConditionList TraitSetID="6739">
          <ClassifiedCondition DB="MedGen" ID="C3150988">Developmental and epileptic encephalopathy, 12</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_007254.4(PNKP):c.1317_1321dup (p.Ala441fs) AND Charcot-Marie-Tooth disease type 2B2" Accession="RCV001814094" Version="4">
        <ClassifiedConditionList TraitSetID="354">
          <ClassifiedCondition DB="MedGen" ID="C1854150">Charcot-Marie-Tooth disease type 2B2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-04-12" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_007254.4(PNKP):c.1317_1321dup (p.Ala441fs) AND Inborn genetic diseases" Accession="RCV003243012" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-12" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2015-06-28" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10446192</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10446193</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15385968</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20852255</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25728773</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28453785</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29655203</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30039206</ID>
        </Citation>
        <DescriptionHistory Dated="2022-01-22">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="354" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="778" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Charcot-Marie-Tooth Neuropathy Type 2B2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2B2</ElementValue>
                <XRef Type="MIM" ID="605589" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Charcot-Marie-Tooth disease type 2B2</ElementValue>
                <XRef ID="MONDO:0011570" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CMT 2B2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Charcot-Marie-Tooth disease, axonal, Type 2B2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Charcot-Marie-Tooth disease, neuronal, Type 2B2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Charcot-Marie-Tooth disease, axonal, autosomal recessive, B2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ARCMT2B</ElementValue>
                <XRef Type="MIM" ID="605589" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">CMT2B2</ElementValue>
                <XRef Type="MIM" ID="605589" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1249" />
                <XRef ID="1249" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="101101" DB="Orphanet" />
              <XRef ID="C1854150" DB="MedGen" />
              <XRef ID="MONDO:0011570" DB="MONDO" />
              <XRef Type="MIM" ID="605589" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6739" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15767" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 12</ElementValue>
                <XRef ID="Epileptic+encephalopathy%2C+early+infantile%2C+12/8340" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 12</ElementValue>
                <XRef ID="MONDO:0013389" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE12</ElementValue>
                <XRef Type="MIM" ID="613722" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13318" />
                <XRef ID="13318" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C3150988" DB="MedGen" />
              <XRef ID="MONDO:0013389" DB="MONDO" />
              <XRef Type="MIM" ID="613722" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="446826" SubmissionDate="2019-01-29" DateLastUpdated="2015-08-07" DateCreated="2015-08-07">
        <ClinVarSubmissionID localKey="GDX:49157|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000242089" DateUpdated="2015-08-07" DateCreated="2015-08-07" Type="SCV" Version="5" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-09-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1317_1321dupAGCCG mutation in the PNKP gene causes a frameshift starting with codon Alanine 441, changes this amino acid to a Glutamic acid residue and creates a premature Stop codon at position 28 of the new reading frame, denoted p.Ala441GlufsX28. This mutation is predicted to cause loss of normal protein function through protein truncation, as the last 81 amino acids of the PNKP protein are lost and replaced with 27 incorrect amino acids. Although this mutation has not been previously reported to our knowledge, it is considered a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="CGGCTCGGCT" referenceAllele="CGGCT" start="50364929" stop="50364930" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_007254.2:c.1317_1321dupAGCCG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="414625" SubmissionDate="2016-11-03" DateLastUpdated="2019-07-31" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="22896_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000226311" DateUpdated="2019-07-31" DateCreated="2015-06-28" Type="SCV" Version="4" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-11-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation Type="general">
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="CGGCT" referenceAllele="-" start="50364929" stop="50364930" variantLength="2" />
            <GeneLocation>NM_007254.3:Ex15</GeneLocation>
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://geneticslab.emory.edu/emvclass/emvclass.php?approved_symbol=PNKP</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL003</SubmissionName>
          <SubmissionName>EGL004</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4041260" SubmissionDate="2022-02-10" DateLastUpdated="2022-02-11" DateCreated="2022-01-22">
        <ClinVarSubmissionID localKey="53594578|OMIM:605589" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002061381" DateUpdated="2022-02-11" DateCreated="2022-01-22" Type="SCV" Version="2" SubmitterName="Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center" OrgID="1019" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>PVS1, PM2</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_007254.4:c.1317_1321dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605589" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10978824</SubmissionName>
          <SubmissionName>SUB11067454</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3113801" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="432083|MedGen:C3150988" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001588142" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29655203</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30039206</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala441Glufs*28) in the PNKP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 81 amino acid(s) of the PNKP protein. This variant is present in population databases (rs796052862, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with epilepsy and/or a neurodevelopmental disease (PMID: 29655203). ClinVar contains an entry for this variant (Variation ID: 206429). This variant disrupts a region of the PNKP protein in which other variant(s) (p.Gln517*) have been determined to be pathogenic (PMID: 30039206). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.50364929_50364930insCGGCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3150988" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7371854" SubmissionDate="2024-04-20" DateLastUpdated="2024-05-01" DateCreated="2023-07-08">
        <ClinVarSubmissionID localKey="a6088661|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003951333" DateUpdated="2024-05-01" DateCreated="2023-07-08" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10446192</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10446193</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15385968</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20852255</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25728773</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28453785</ID>
          </Citation>
          <Comment>The c.1317_1321dupAGCCG (p.A441Efs*28) alteration, located in exon 15 (coding exon 14) of the PNKP gene, consists of a duplication of AGCCG at position 1317, causing a translational frameshift with a predicted alternate stop codon after 28 amino acids. This alteration occurs at the 3' terminus of the PNKP gene, is not expected to trigger nonsense-mediated mRNA decay, and impacts the last 15% of the protein. Premature stop codons are typically deleterious in nature, the impacted region is critical for protein function, and a significant portion of the protein is affected (Ambry internal data). This allele was reported in one heterozygous individual in population-based cohorts in the Genome Aggregation Database (gnomAD). This alteration was detected in conjunction with another variant in PNKP in an individual with clinical features of PNKP-related neurodevelopmental disorder (Bras, 2015). Based on internal structural analysis, p.A441Efs*28 is deleterious. This variant is destabilizing to the local structure and disrupts a significant portion of a domain (Jilani, 1999; Karimi-Busheri, 1999; Koch, 2004; Mani, 2010; Aceytuno, 2017). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_007254.3:c.1317_1321dupAGCCG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough061523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_2</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="414625" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="446826" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4041260" TraitType="Disease" MappingType="XRef" MappingValue="605589" MappingRef="OMIM">
        <MedGen CUI="C1854150" Name="Charcot-Marie-Tooth disease type 2B2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3113801" TraitType="Disease" MappingType="XRef" MappingValue="C3150988" MappingRef="MedGen">
        <MedGen CUI="C3150988" Name="Developmental and epileptic encephalopathy, 12" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7371854" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

